Projektdaten
SGLT2-inhibition to improve Prognosis in Polycystic Kidney Disease
Hochschule
Universitätsklinikum Jena
Fakultät/Einrichtung
Medizinische Fakultät
Förderkategorie
Auftragsforschung
Zeitraum
2025 - 2028
Drittmittelgeber
Universität zu Köln
Stichwort
Bewilligungssumme, Auftragssumme
Kategorie 5.000,00 - 9.999,00 €
Abstract:
SGLT2-inhibitors (SGLT2i) prevent the loss of kidney function in chronic kid-ney disease (CKD) at a highly positive side effect profile but have not been ex-amined in ADPKD. We hypothesize that SGLT2i slow down kidney function loss in ADPKD by 30%, a clinically meaningful effect delaying kidney failure by 1 year for each 3 years of treatment.